The efficacy and safety of Yupingfeng Powder with variation in the treatment of allergic rhinitis: Study protocol for a randomized, double-blind, placebo-controlled trial

Background: Allergic rhinitis (AR) is an upper airways chronic inflammatory disease mediated by IgE, which affects 10%–20% of the population. The mainstay for allergic rhinitis nowadays include steroids and antihistamines, but their effects are less than ideal. Many patients therefore seek Chinese m...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheong, Pui Kuan, Ho, Tin Muk, Chan, Kam Leung, Lo, Cho Wing, Leung, Sin Bond, Hon, Kam Lun, Leung, Ka Chun, Siu, Tony Hon Chung, Song, Tian-He, Zhang, Hongwei, Ching, Jessica Yuet Ling, Chow, Tak Yee, Sum, Chi Him, Chia, Chon Pin, Lin, Zhi-Xiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800420/
https://www.ncbi.nlm.nih.gov/pubmed/36588672
http://dx.doi.org/10.3389/fphar.2022.1058176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800420/
https://www.ncbi.nlm.nih.gov/pubmed/36588672
http://dx.doi.org/10.3389/fphar.2022.1058176

Ejemplares similares